七月 2026
- Home
- Hester Biosciences
七月 2026的Hester Biosciences市场份额分析
hester biosciences limited is one of india's leading animal healthcare companies and is the second largest poultry vaccine manufacturer in the country.
Hester Biosciences(包含公司地区分支机构)
查看更多网站流量和参与度信息- hester.in
Hester Biosciences收入截至 七月 2026为 25M - 50M
Hester Biosciences主要域名产生的收入
3 年中Hester Biosciences主要域名的收入
Hester Biosciences主要域名的收入
Hester Biosciences热门域名的总访问量
了解Hester Biosciences市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Hester Biosciences热门域名的平均访问时长
分析Hester Biosciences参与度指标。
过去 3 个月的平均访问时长
子公司明细
Hester Biosciences热门域名的平均页面浏览量
了解Hester Biosciences如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Hester Biosciences 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Hester Biosciences Limited had earnings of $10.2M on Jun 1st '26.Hester Biosciences Ltd., one of India's leading animal health companies, manufacturing vaccines and health products, has reported consolidated net profit of Rs. 96.73 crore for the quarter ended June 2026, a rise of 459% Y-o-Y as compared to the net profit of Rs. 17.30 crore reported in Q1 FY26.
八月 5, 2026阅读更多
新闻Hester Biosciences Limited recognized as top small-cap companies with the highest EPS on Jan 1st '26.Synopsis: Five stocks including Hester Biosciences, Just Dial, and a few others emerged among the top small-cap companies with the highest EPS, backed by healthy growth in revenue, profitability, and earnings during FY26.
七月 14, 2026阅读更多
新闻Hester Biosciences Limited has earnings of $1.82M.Net profit of Hester Biosciences rose 1138.76% to Rs 15.98 crore in the quarter ended March 2026 as against Rs 1.29 crore during the previous quarter ended March 2025.
五月 15, 2026阅读更多
查看 Hester Biosciences 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
